amicus closes below its ipo price new york after a promising start shares of health care company amicus therapeutics inc closed below its initial public offering price the ipo of the cranbury n j based company closed at &# on nasdaq compared with its &# ipo price and its &# opening price it priced at the midpoint of its range through morgan stanley and merrill lynch &amp co amicus focuses on drugs known as pharmacological chaperones for treating genetic diseases amicuss debut came after the expected price range of another ipo jazz pharmaceuticals inc was cut to a range of &# to &# from &# ahead of its scheduled debut on nasdaq today despite the mixed reception for health care ipos the sector remains the busiest 
